299 related articles for article (PubMed ID: 33571506)
1. Clinical Significance of Interstitial Lung Disease and Its Acute Exacerbation in Microscopic Polyangiitis.
Hozumi H; Kono M; Hasegawa H; Yasui H; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
Chest; 2021 Jun; 159(6):2334-2345. PubMed ID: 33571506
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of acute exacerbation in interstitial lung disease with antineutrophil cytoplasmic antibody: an indicator of poor prognosis.
Wu T; Zhang Y; Cen Z; Ying Y; Sun C; Lv C; Ding Q
Ther Adv Respir Dis; 2022; 16():17534666221140974. PubMed ID: 36484348
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease.
Matsuda S; Kotani T; Suzuka T; Kiboshi T; Fukui K; Wakama M; Ishida T; Fujiki Y; Shiba H; Nagai K; Hata K; Shoda T; Ito Y; Makino S; Takeuchi T
Sci Rep; 2021 Jan; 11(1):1490. PubMed ID: 33452394
[TBL] [Abstract][Full Text] [Related]
4. Clinical differences among patients with myeloperoxidase-antineutrophil cytoplasmic antibody-positive interstitial lung disease.
Yamaguchi K; Yamaguchi A; Ito M; Wakamatsu I; Itai M; Muto S; Uno S; Aikawa M; Kouno S; Takemura M; Yatomi M; Aoki-Saito H; Koga Y; Hara K; Motegi S; Tsukida M; Ota F; Tsukada Y; Motegi M; Nakasatomi M; Sakairi T; Ikeuchi H; Kaneko Y; Hiromura K; Maeno T
Clin Rheumatol; 2023 Feb; 42(2):479-488. PubMed ID: 36194347
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features and survival analysis of microscopic polyangiitis-associated interstitial lung disease:a retrospective study of 28 patients].
Wu TT; Cen ZK; Zhou HJ; Sun C; Tang P; Zhang Y; Ding QL
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Oct; 45(10):1022-1030. PubMed ID: 36207959
[No Abstract] [Full Text] [Related]
6. Prediction model for respiratory-related mortality in microscopic polyangiitis with interstitial lung disease: multicentre REVEAL cohort study.
Matsuda S; Kotani T; Okazaki A; Nishioka D; Watanabe R; Gon T; Manabe A; Shoji M; Kadoba K; Hiwa R; Yamamoto W; Hashimoto M; Takeuchi T
Rheumatology (Oxford); 2024 May; 63(6):1607-1615. PubMed ID: 37632776
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of microscopic polyangiitis with interstitial lung disease and bronchiectasis: probability of preexisting comorbidities.
Zhang Y; Ding Q; Lv C; Ying Y; Cen Z; Zhou H; Wu T
Ann Med; 2023 Dec; 55(1):2204449. PubMed ID: 37126372
[TBL] [Abstract][Full Text] [Related]
8. Long-term survival, causes of death, and prognostic factors for mortality in patients with microscopic polyangiitis and those with anti-neutrophil cytoplasmic antibody-positive interstitial lung disease: A single-center retrospective study.
Takakuwa Y; Yamasaki Y; Matsushita H; Kiyokawa T; Mizushima M; Tonooka K; Nagafuchi H; Matsuoka S; Ooka S; Kawahata K
Int J Rheum Dis; 2023 Mar; 26(3):446-453. PubMed ID: 36502537
[TBL] [Abstract][Full Text] [Related]
9. Clinical features and long-term outcomes of interstitial lung disease with anti-neutrophil cytoplasmic antibody.
Sun X; Peng M; Zhang T; Li Z; Song L; Li M; Shi J
BMC Pulm Med; 2021 Mar; 21(1):88. PubMed ID: 33726733
[TBL] [Abstract][Full Text] [Related]
10. Acute Respiratory Deterioration in Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Single-Center Study.
Kwon BS; Lee HY; Choe J; Chae EJ; Hong S; Song JW
Chest; 2022 Jul; 162(1):136-144. PubMed ID: 35032476
[TBL] [Abstract][Full Text] [Related]
11. Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model.
Hozumi H; Kono M; Hasegawa H; Kato S; Inoue Y; Suzuki Y; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Inui N; Nakamura Y; Yokomura K; Nakamura H; Suda T
Respir Res; 2022 Mar; 23(1):57. PubMed ID: 35277175
[TBL] [Abstract][Full Text] [Related]
12. Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases.
Adegunsoye A; Oldham JM; Bellam SK; Montner S; Churpek MM; Noth I; Vij R; Strek ME; Chung JH
Ann Am Thorac Soc; 2019 May; 16(5):580-588. PubMed ID: 30653927
[No Abstract] [Full Text] [Related]
13. Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology.
Manfredi A; Cassone G; Izzo R; Dallagiacoma G; Felicetti M; Cariddi A; Berti A; Giollo A; Nannini C; Bettio S; Monti S; Conticini E; Govoni M; Quartuccio L; Argolini LM; Kaleci S; Emmi G; Dejaco C; Padoan R; Dagna L; Rossini M; Cantini F; Montecucco C; Frediani B; De Vita S; Caporali R; Muratore F; Sebastiani M; Salvarani C;
Clin Exp Rheumatol; 2023 Apr; 41(4):821-828. PubMed ID: 36200955
[TBL] [Abstract][Full Text] [Related]
14. Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis.
Xie M; Zhu C; Ye Y
BMC Pulm Med; 2023 Jul; 23(1):255. PubMed ID: 37434169
[TBL] [Abstract][Full Text] [Related]
15. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
[TBL] [Abstract][Full Text] [Related]
16. Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single-Centre Observational Study.
Ha JW; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
J Immunol Res; 2022; 2022():2499404. PubMed ID: 35655922
[TBL] [Abstract][Full Text] [Related]
17. Early interstitial lung disease in microscopic polyangiitis: Case report and literature review.
García-Nava M; Mateos-Toledo H; Guevara-Canseco APG; Infante-González CE; Reyes-Nava DA; Estrada-Castro E
Reumatol Clin (Engl Ed); 2018; 14(2):106-108. PubMed ID: 27919708
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical course and outcomes of patients with microscopic polyangiitis-associated interstitial lung disease.
Kim MJ; Lee D; Choe J; Song JW
Front Pharmacol; 2023; 14():1064307. PubMed ID: 36794274
[No Abstract] [Full Text] [Related]
19. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
[TBL] [Abstract][Full Text] [Related]
20. Characteristics and Prognosis of Microscopic Polyangiitis Patients with Diffuse Alveolar Hemorrhage and Interstitial Lung Disease.
Gu Y; Zhang T; Peng M; Shi JH
Chin Med Sci J; 2022 Dec; 37(4):293-302. PubMed ID: 36000390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
